Related Experiment Video
Updated: Jun 2, 2026
09:34
Implementation of Portable Emissions Measurement Systems (PEMS) for the Real-driving Emissions (RDE) Regulation in Europe
Published on: December 4, 2016
Regulatory pathways in the European Union
1Pharmatching GmbH, Freiburg, Germany. manuela.kohler@pharmatching.com
Mabs
|April 14, 2011
Summary
Navigating European Union medicinal product approval involves three main regulatory pathways. The choice depends on the drug
Area of Science:
- Pharmaceutical regulatory affairs
- Drug development and approval processes
Background:
- The European Union (EU) has established specific regulatory frameworks for medicinal product authorization.
- Understanding these pathways is crucial for pharmaceutical companies seeking market access.
Purpose of the Study:
- To provide an overview of the three defined procedures for obtaining medicinal product approval in the EU.
- To guide stakeholders in selecting the appropriate regulatory pathway based on product-specific factors.
Main Methods:
- This document provides a descriptive overview of existing regulatory procedures.
- It synthesizes information on factors influencing pathway selection.
Main Results:
- Three distinct regulatory procedures exist for EU medicinal product approval.
- Key decision factors include the active substance, target indications, product history, and marketing strategy.
Conclusions:
- The selection of the optimal regulatory pathway is a strategic decision.
- A thorough understanding of the drug's characteristics and market goals is essential for successful EU market authorization.
Related Concept Videos
01:28Global Regulatory Systems
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
01:03Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
02:39Positive Regulator Molecules
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
01:45Positive Regulator Molecules
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
02:39Positive Regulator Molecules
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...